Explore This Research Award in CaptureIQ
Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.
Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- INNOVATIONS UNLIMITED LLC
- Proposal award date
- 2020-09-18
- Contract end date
- 2022-07-31
- UEI
- E6PTT4HZN387
- Solicitation number
- PA19-272
- Topic code
- 600
Research abstract
Tracheostomy provides a critical, life-supporting function for over 6.5 million individuals in the U.S. with over
110,000 new procedures each year. The TrachAlarm is a novel, low-cost accessory to automatically detect and
alert caregivers when a tracheostomy tube is accidentally removed from a patient. It provides a low-cost,
accessible solution for tracheostomy patients and caregivers by utilizing magnetic sensing and smart alarms.
The system integrates magnetic sensors in the patient dressing, and an alarm unit that easily connects to a
tracheostomy flange and trach-tie. When the dressing is placed on the patient’s neck, magnetic sensors
automatically align (around the periphery of the stoma) with the trachea insertion location. The alarm unit includes
circuitry to detect the magnetic field. If the tube is moved away from the trachea, the alarm unit moves along with
it, removing the detected magnetic field, creating an audible and visual alarm for the caregiver.Significant innovations distinguish the TrachAlarm from other market technologies. First, existing sensors
and alarms are only available on ventilators that may be connected, but not for patients not requiring ventilators.
Second, magnetic field technology provides a low-cost, low-burden device, easy for caregivers to use. These
features will greatly improve technology accessibility to wide ranging demographics and socioeconomic
disparate populations. Finally, accurate and automated alarms provide a significant benefit to patients by
improving safety and preventing adverse events with overall burden to caregivers reduced.Phase II will expand upon successful Phase I prototype results to launch a commercially and clinically
deployable TrachAlarm. The project is strategically positioned with four main objectives over a two-year period
with specific tasks and success milestones. Aim 1 will use Phase I results to optimize device components, system
packaging and alarm delivery. This includes finalizing all electronic components, device form factor, and
developing all system packaging, user guides, and labeling for shipping and use. This task will enhance device
safety and effectiveness by extending the on-device alarm to wireless mobile alarming. All modifications and
additions will be technically verified by formal test cases. Aim 2 will target algorithmic enhancements to the
alarming strategy to optimize both sensitivity and specificity. While the device requires 100% sensitivity, it is
critical high specificity is also achieved to ensure users respond to the alarm when it occurs. Aim 3 will transition
all engineering designs to formal manufacturing and quality procedures. This will include scaling the design for
large scale production, minimizing costs, supplier assessments, and assembly instructions. A pre-production run
of devices using the full-scale manufacturing procedures will be tested as per all required input specifications,
medical device standards, and quality regulations. Finally, Aim 4 will complete a final update to any device design
or manufacturing procedures and produce first article devices. These devices will be implemented in a large-
scale field usability study to determine performance, effectiveness, and safety in the target user population.Project Narrative
A solution to Accidental Decannulation/Tracheal Dislodgement, continues to be an unmet need
for patients living with tracheostomy tubes. Development of the TrachAlarm™, which alerts the
caregiver of movement of the tracheostomy tube from its desired position, or that it has
completely dislodged, will allow the caregiver to immediately recognize the event and reinsert
the tracheostomy tube in a timely manner and significantly decrease the number of deaths or
irreversible damage resulting from same. More than 50,000 patients have suffered from either
permanent damage or death resulting from accidental decannulation/tracheal dislodgement in
hospitals, health care facilities, and at home.
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
Research funding history
2 SBIR/STTR records share this UEI (2018–2020). Reported award amounts total $1,944,792. Reported amounts are not federal obligations.
Phases: Phase II, Phase I
Agencies: Department of Health and Human Services
Agency intelligence
Department of Health and Human Services
Back to SBIR/STTR Research Awards